SC Asset Announces Global Launch Roadshow for “REFERENCE SATHORN – WONGWIANYAI” in Hong Kong, Singapore, and Taipei This July

SC Asset, one of Thailand's leading real estate developers, is proud to announce theGlobal Launch Roadshow for its flagship river view condominium project, REFERENCE SATHORN – WONGWIANYAI, this July 18-19. The international showcase will be held in three strategic locations across Asia: Hong Kong, Singapore, and Taipei, reflecting the company's commitment to meeting growing regional […]

Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions

(NASDAQ:WINT), WARRINGTON, Pa., July 16, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is excited to announce it has entered into a $60 million securities purchase agreement led by Build and Build Corp, with the potential for up to an additional $140 million in gross proceeds in future subscriptions, for

Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions

Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions Windtree expected to become a leader and the first NASDAQ-listed company offering direct exposure to the Binance Smart Chain Ecosystem (BNB) GlobeNewswire July 16, 2025 WARRINGTON,

Hong Kong Book Fair, Sports and Leisure Expo and World of Snacks open today

– A Hong Kong spotlight event in July and a feature of Hong Kong Summer Viva, the Hong Kong Book Fair opened today alongside the Sports and Leisure Expo and World of Snacks. More than 770 exhibitors are participating in the three events– With "Food Culture Future Living" as the theme of the year, the

Genetic Leap receives FDA IND clearance for first-in-class, oral natural IL-2 modulator

GL-IL2-138 is a small molecule RNA agent that modulates natural IL-2, allowing for downregulating or upregulating the immune system to fight devastating diseases Potential to unite Humira-grade inflammation control and Keytruda-class anti-cancer power in a single pill, without the drawbacks Genetic Leap, a clinical stage, AI-native biotech pioneering RNA genetic therapeutics, announced today that the

SANS Institute to Host Free Virtual Government Security Forum on July 22, 2025, Delivering Actionable Cyber Guidance for Public Sector and Critical Infrastructure Teams

Bethesda, MD, July 16, 2025 (GLOBE NEWSWIRE) — Cyberattacks on U.S. utilities surged 70% in 2024, according to a Check Point report, while attacks on critical infrastructure rose approximately 30% in 2023, based on data from the CISA Year in Review. These trends paint a clear picture: government systems and infrastructure remain prime targets, often

SANS Institute to Host Free Virtual Government Security Forum on July 22, 2025, Delivering Actionable Cyber Guidance for Public Sector and Critical Infrastructure Teams

SANS Institute to Host Free Virtual Government Security Forum on July 22, 2025, Delivering Actionable Cyber Guidance for Public Sector and Critical Infrastructure Teams Featuring insights from White House, DoD, DHS, and SANS experts, the event offers practical guidance for defending public sector systems and infrastructure. GlobeNewswire July 16, 2025 Bethesda, MD, July 16, 2025

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain

(NASDAQ:OKYO), After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly effective treatment. Urcosimod (0.05%) demonstrated a marked reduction in pain scores as early as Week 4, with sustained efficacy maintained throughout the trial.

Arctic Pablo Coin Launches 32nd Presale Phase at Icebound Estates With $2.93M Raised and Deflationary Token Burn Model

LONDON, July 16, 2025 (GLOBE NEWSWIRE) — Crypto investors are taking notice as Arctic Pablo Coin ($APC) reaches a major milestone in its ongoing presale campaign, now entering its 32nd location, Icebound Estates. With over $2.93 million already raised and a price point of $0.0005 per token, the project's cinematic storyline and deflationary mechanics are

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain GlobeNewswire July 16, 2025 After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly effective treatment. Urcosimod (0.05%)

Scroll to Top